anti-CEACAM1 mAbs (University of Duisburg-Essen)

N/A

Report date: 2025/03/14 16:48:31

Base Information

Drug Nameanti-CEACAM1 mAbs (University of Duisburg-Essen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo)
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 1 modulators
TargetsCarcinoembryonic antigen related cell adhesion molecule 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat Duisburg Essen
China Registration ClassN/A

Develop Information

Active CompaniesPROvendis GmbHUniversitat Duisburg Essen
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A